Reuptake inhibitor
Top View
- JN1540 Depression Whitepaper 3.Indd
- A Randomized Trial of an N-Methyl-D-Aspartate Antagonist in Treatment-Resistant Major Depression
- Antidepressants: Mechanism of Action, Toxicity and Possible Amelioration
- Onset Antidepressant Effect? a Concise Overview of the Surprisingly Large Number of Possibilities
- Nicotinic Acetylcholine Receptors Interact with Dopamine in Induction of Striatal Long-Term Depression
- Non-Psychotropic Plant Cannabinoids: New Therapeutic Opportunities from an Ancient Herb
- Identification of Novel α4β2-Nicotinic Acetylcholine Receptor (Nachr) Agonists Based on an Isoxazole Ether Scaffold That Demonstrate Antidepressant-Like Activity
- Neuronal 5-HT Receptors and SERT
- Neuromodulation in the Management of Allergic Chronic Vaginitis
- Drug Class Review Selective Serotonin Reuptake Inhibitors
- Neuromodulation for Treatment-Refractory Major Depressive Disorder
- Elsevier Editorial System(Tm) for Trends in Pharmacological Sciences Manuscript Draft
- Cannabinoids and Mental Health
- Sertraline-Induced Pseudocholinesterase Enzyme Deficiency
- Serotonin-Dopamine Interactions in the Control of Conditioned Reinforcement and Motor Behavior Deanna M
- A Guide to Targeting the Endocannabinoid System in Drug Design
- Exploring the Gating Pathway in an Eukaryotic Ligand-Gated Ion Channel
- Dissociable Antidepressant-Like and Abuse-Related Effects of the Noncompetitive NMDA Receptor Antagonists Ketamine and MK-801 in Rats